Spinal cord injury: pathophysiology, possible treatments and the role of the gut microbiota
- PMID: 39744391
- PMCID: PMC11688470
- DOI: 10.3389/fmicb.2024.1490855
Spinal cord injury: pathophysiology, possible treatments and the role of the gut microbiota
Abstract
Spinal cord injury (SCI) is a devastating pathological state causing motor, sensory, and autonomic dysfunction. To date, SCI remains without viable treatment for its patients. After the injury, molecular events centered at the lesion epicenter create a non-permissive environment for cell survival and regeneration. This newly hostile setting is characterized by necrosis, inflammation, demyelination, axotomy, apoptosis, and gliosis, among other events that limit locomotor recovery. This review provides an overview of the pathophysiology of SCI, highlighting the potential role of the gut microbiota in modulating the inflammatory response and influencing neurological recovery following trauma to the spinal cord. Emphasis on the bidirectional communication between the gut and central nervous system, known as the gut-brain axis is given. After trauma, the gut-brain/spinal cord axis promotes the production of pro-inflammatory metabolites that provide a non-permissive environment for cell survival and locomotor recovery. Therefore, any possible pharmacological treatment, including antibiotics and painkillers, must consider their effects on microbiome dysbiosis to promote cell survival, regeneration, and behavioral improvement. Overall, this review provides valuable insights into the pathophysiology of SCI and the evolving understanding of the role of the gut microbiota in SCI, with implications for future research and clinical practice.
Keywords: dysbiosis; gut microbiome; gut-brain axis; neurodegenerative; spinal cord trauma.
Copyright © 2024 Pagan-Rivera, Ocasio-Rivera, Godoy-Vitorino and Miranda.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
The spinal cord-gut-immune axis as a master regulator of health and neurological function after spinal cord injury.Exp Neurol. 2020 Jan;323:113085. doi: 10.1016/j.expneurol.2019.113085. Epub 2019 Oct 22. Exp Neurol. 2020. PMID: 31654639 Free PMC article. Review.
-
Gut Microbiota and Tryptophan Metabolism as Therapeutic Targets for Spinal Cord Injury: Insights From Probiotic Treatment.J Inflamm Res. 2025 Jun 7;18:7337-7355. doi: 10.2147/JIR.S513900. eCollection 2025. J Inflamm Res. 2025. PMID: 40503491 Free PMC article.
-
Spinal Cord-Gut-Immune Axis and Its Implications Regarding Therapeutic Development for Spinal Cord Injury.J Neurotrauma. 2023 May;40(9-10):793-806. doi: 10.1089/neu.2022.0264. Epub 2023 Mar 10. J Neurotrauma. 2023. PMID: 36509451 Review.
-
Beyond the lesion site: minocycline augments inflammation and anxiety-like behavior following SCI in rats through action on the gut microbiota.J Neuroinflammation. 2021 Jun 26;18(1):144. doi: 10.1186/s12974-021-02123-0. J Neuroinflammation. 2021. PMID: 34174901 Free PMC article.
-
Traumatic Spinal Cord Injury and the Gut Microbiota: Current Insights and Future Challenges.Front Immunol. 2020 May 8;11:704. doi: 10.3389/fimmu.2020.00704. eCollection 2020. Front Immunol. 2020. PMID: 32528463 Free PMC article. Review.
Cited by
-
Acceleration of axonal regeneration by GABA/Gly excitation.Anat Sci Int. 2025 Jul 9. doi: 10.1007/s12565-025-00869-8. Online ahead of print. Anat Sci Int. 2025. PMID: 40632480 Review.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources